Showing results (111-120 of 214) with videos related to
Sort By:
Pageof 22
ASM Case Reports|November 17, 2025
Delayed diagnosis of disseminated <i>Mycobacterium intracellulare</i> subsp. <i>chimaera</i> infective endocarditis via cell-free metagenomic next-generation sequencing: a case reportJoseph Benigno Ladines-Lim, Wei-Teng Yang, Pablo Tebas, et al.Journal of Virology|June 22, 2022
Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition ScreenSavannah F Pedersen, Jack A Collora, Rachel N Kim, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102Keith Henry, David Katzenstein, Deborah Weng Cherng, et al.HIV Clinical Trials|December 17, 2013
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trialValerianna K Amorosa, Anne Luetkemeyer, Minhee Kang, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 5, 2010
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200Michael F Para, Jeff Schouten, Susan L Rosenkranz, et al.Antiviral Therapy|August 30, 2013
Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) studyDavid A Wohl, Gretchen Arnoczy, Carl J Fichtenbaum, et al.The Journal of Infectious Diseases|October 23, 2024
Evaluation and Real-world Experience of a Neutralization Susceptibility Screening Assay for Broadly Neutralizing Anti-HIV-1 AntibodiesMarie Høst Pahus, Yu Zheng, Maxine Olefsky, et al.AIDS (London, England)|October 18, 2005
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosidesMichael P Dubé, Robert A Parker, Pablo Tebas, et al.Plos Neglected Tropical Diseases|October 29, 2020
A novel synthetic DNA vaccine elicits protective immune responses against Powassan virusHyeree Choi, Sagar B Kudchodkar, Michelle Ho, et al.The Journal of Gene Medicine|January 17, 2013
Patient monitoring and follow-up in lentiviral clinical trialsGerard J McGarrity, Gloria Hoyah, April Winemiller, et al.Pageof 22